Fibroblast Growth Factors/Fibroblast Growth Factor Receptors as Targets for the Development of Anti-Angiogenesis Strategies

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|13|20|2025-2044

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.13, Iss.20, 2007-07, pp. : 2025-2044

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Basic fibroblast growth factor and the complexity of tumour angiogenesis

By Rak J.   Kerbel R.S.  

Expert Opinion on Investigational Drugs, Vol. 7, Iss. 5, 1998-05 ,pp. : 797-801

Informa Healthcare

Access to resources Recommend Favorite

Fibroblast Growth Factors and Their Inhibitors

By  

Current Pharmaceutical Design, Vol. 6, Iss. 18, 2000-12 ,pp. : 1897-1924

Bentham Science Publishers

Access to resources Recommend Favorite

Beyond angiogenesis: the cardioprotective potential of fibroblast growth factor-2

By Detillieux Karen A   Cattini Peter A   Kardami Elissavet  

Canadian Journal of Physiology and Pharmacology, Vol. 82, Iss. 12, 2004-12 ,pp. : 1044-1052

NRC Research Press

Access to resources Recommend Favorite

Fibroblast Growth Factor Receptor Inhibitors

By  

Current Pharmaceutical Design, Vol. 19, Iss. 4, 2013-02 ,pp. : 687-701

Bentham Science Publishers

Access to resources Recommend Favorite

Growth Factors and Bone Formation in Osteoporosis: Roles for Fibroblast Growth Factor and Transforming Growth Factor Beta

By  

Current Pharmaceutical Design, Vol. 10, Iss. 21, 2004-08 ,pp. : 2593-2603

Bentham Science Publishers

Access to resources Recommend Favorite